The Research and Development Department works on the basis of innovative research platforms. We research innovative drugs for treating cancer and central nervous system diseases.
WE CONNECT ACADEMIA AND BUSINESS
In 2001, Adamed became the first Polish pharmaceutical company to initiate research into innovative drugs. We currently focus on the areas of oncology and central nervous system diseases. We carry out our projects in cooperation with leading research facilities both in Poland and abroad.
The dynamic development of Adamed Group’s products is made possible by advanced technological infrastructure - we operate one of the first biotechnological and biofermentation lines in Poland, our own GMO lab, a NIH panel (a panel of cancerous cell lines, designed by the American National Cancer Institute, used to conduct research of anticancer particles.
Find out about our innovative projects.
The Chemistry Lab synthesizes new chemical compounds which may be used to produce innovative drugs in the future. The Biology Lab is outfitted with cutting-edge equipment used to conduct research combining biochemistry, physiology, molecular biology and biotechnology. Other departments of the Research and Development Division support the processes of seeking new solutions, in the areas of generic and innovative drugs, as well as introducing them to the market. Professionally trained staff, in-depth knowledge of pharmaceutics and patent law, as well as efficient organizational systems allow us to efficiently implement solutions devised by our scientists.
THE RESEARCH AND DEVELOPMENT DIVISION IS MADE UP OF THE FOLLOWING DEPARTMENTS: RESEARCH, PROJECT MANAGEMENT, REGISTRATION AND CLINICAL STUDIES
Since the very start of our company’s operations, we have been cooperating with the scientific and academic community by supporting promising research initiatives.
MEDICAL UNIVERSITY OF GDAŃSK
ISTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY
ISTITUTE OF EXPERIMENTAL BIOLOGY
UNIVERSITY OF WARSAW
GDAŃSK UNIVERSITY OF TECHNOLOGY IN GDAŃSK